Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
Titel:
Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
Auteur:
Philis-Tsimikas, Athena Klonoff, David C. Khunti, Kamlesh Bajaj, Harpreet S. Leiter, Lawrence A. Hansen, Melissa V. Troelsen, Lone N. Ladelund, Steen Heller, Simon Pieber, Thomas R. ,